Skip Navigation LinksHome » News » Sanbio B.V. acquired the rights on a selected range of cell Lines from Pathology Department VU Medical Center in The Netherlands

Sanbio B.V. acquired the rights on a selected range of cell Lines from Pathology Department VU Medical Center in The Netherlands


To further expand the Monosan® antibody product line, Sanbio B.V. acquired the rights of a selected group of cell lines from the Pathology Department of VU Medical Center, as per October 1st, 2012. Sanbio B.V. has been a strategic partner of the pathology department for over 20 years. Sanbio B.V. has started the production of the VUmc clones in their own laboratories and the antibodies will be made available at the same specifications as in the past, meaning the highest possible standards in specificity and purity. Sanbio B.V. will supply the products to the market under it's own Monosan® brand name.
Sanbio B.V., established in 1978, is an independent supplier and manufacturer of innovative products and services in the field of life science, based in Uden, The Netherlands. MONOSAN®, the brand name of Sanbio B.V. is a product line with commercially available antibodies. MONOSAN®,  contains over 2000 monoclonal and polyclonal antibodies and reagents which are being developed and commercialized either in their own laboratories or in collaboration with some of the leading universities and research institutes throughout Europe. At this moment the Monosan products are marketed and sold worldwide through a network of approved and service-conscious distributors and OEM partners in 50 different countries.

Download PDF

Back to news page